NovaBridge Biosciences American Depositary Shares
NBP
38 hedge funds and large institutions have $25.3M invested in NovaBridge Biosciences American Depositary Shares in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 18 reducing their positions, and 4 closing their positions.
67% more call options, than puts
Call options by funds: $5K | Put options by funds: $3K
12% more capital invested
Capital invested by funds: $22.7M → $25.3M (+$2.65M)
3.61% more ownership
Funds ownership: 15.11% → 18.72% (+3.6%)
3% less funds holding
Funds holding: 39 → 38 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
72% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CP
Caligan Partners
New York
|
+$4.68M |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$1.79M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$438K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$69.2K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$55.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$287K |
| 2 |
CFM
Catalyst Funds Management
Sydney NSW,
Australia
|
-$261K |
| 3 |
Man Group
London,
United Kingdom
|
-$251K |
| 4 |
Two Sigma Investments
New York
|
-$174K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$151K |
NBP Hedge Fund Activity: Q2 2024 in Review
38 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q2 2024, worth a combined $25.3M — up 12% from $22.7M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NBP and 3 opened new positions — a net loss of 1 holder — while 18 trimmed existing stakes and 5 added.
The largest buyer was Caligan Partners, adding an estimated $4.68M. The largest seller was GSA Capital Partners, cutting an estimated $287K.
- 38 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q2 2024, down from 39 in Q1 2024.
- Funds reported $25.3M of NovaBridge Biosciences American Depositary Shares stock for Q2 2024, up 12% quarter-over-quarter.
- 3 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q2 2024 and 4 closed out, a net change of -1 holder.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q2 2024 was Caligan Partners, an estimated $4.68M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q2 2024 was GSA Capital Partners, an estimated $287K sold.
Based on aggregated 13F filings for Q2 2024.